Navigation Links
ViroPharma to Present at the Susquehanna Financial Group Second Annual Significant Options in Healthcare Conference
Date:2/28/2008

EXTON, Pa., Feb. 28 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced it will present at the Susquehanna Financial Group Second Annual Significant Options in Healthcare Conference at 1:30 P.M. ET on Wednesday, March 5, 2008. The conference is being held at The W Hotel, in New York City.

ViroPharma's presentation will be webcast live for investors through http://www.viropharma.com and available for a period of 14 days following the conference.

About ViroPharma Incorporated

ViroPharma Incorporated is a biopharmaceutical company dedicated to the development and commercialization of products that address serious diseases treated by physician specialists and in hospital settings. ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin- resistant strains (for prescribing information, please download the package insert at http://www.viropharma.com/Products.aspx). ViroPharma currently focuses its drug development activities in viral diseases including cytomegalovirus (CMV) and hepatitis C (HCV). For more information on ViroPharma, visit the company's website at http://www.viropharma.com.


'/>"/>
SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. ViroPharma to Present at Two Upcoming Healthcare Conferences
2. ViroPharma Provides 2008 Outlook
3. ViroPharma to Present at the BIO CEO & Investor Conference
4. ViroPharma to Release 2007 Fourth Quarter and Full Year Financial Results on February 27, 2008
5. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
6. Avicena Group to Present at Noble Financial Conference
7. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
8. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
9. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
10. CEL-SCI to Present at the Noble Financial Conference
11. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...man . , Whether it,s CD packaging, container...ncy Identification) are increasingly finding their...label objects or goods and identify them automatic...an read and process the data contained in the labe...uction conditions of up to 100 degrees Celsius. Bu...
(Date:11/24/2009)...tario, Nov. 24 Dow AgroS... assets of Hyland Seeds, a division of Thompsons L...d Seeds will further expand Dow AgroSciences, curr...introduction of SmartStax(TM) in 2010 and Do... in corn in 2012. The transactional close is expec...
(Date:11/24/2009)... /PRNewswire-Asia/ -- NOD Pharmaceuticals Inc. ann...has allowed the patent application for,its nano-pa... NOD technology is a highly efficient approach to ... nano-particles to enable oral delivery of drugs,o...y is a platform technology,that can be applied to ...
(Date:11/24/2009)...ndpoint has been met for patients with advanced-st...EBEC CITY, Nov. 24 /PRNewswire-FirstCall/ - AEtern...ompany"), a global biopharmaceutical company focus...ced positive efficacy data from a Phase 2 study wi...108 (formerly AN-152), in patients with advanced o...
Breaking Biology Technology:Intelligence inside metal components 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
...erapeutics (Nasdaq: NKTR ) will announce its fina..., 2008 on Wednesday, May 7, 2008, after the,close ...sident and chief,executive officer, will host a co...(ET)., Investors can access the press release and...through a link that is posted on the Investor Rela...
...b,Company (NYSE: BMY ) invites investors and the ...l meeting with stockholders at 10 a.m. ET on Tuesd... board items to be,transacted, senior executives w... For information on how to listen to the webcast, ...istol-Myers Squibb website at, http://www.bms.com/...
...obal competition,and today,s networked economy hav... Strategic Alliances as the strategy of the next c...uation for it to be sustainable and,mutually benef...ctices, LLC,s study on Forging,Partnerships That W... This,study evaluates the significance of 10 facto...
Other Biology Technology:Nektar to Announce Q1 2008 Financial Results on Wednesday, May 7, 2008, After Close of U.S.-Based Financial Markets 2Biopharmaceutical Alliances: Forging Partnerships That Work 2
(Date:11/24/2009)...has been prescribed by traditional healers in Braz... stomach pain to fever and flu. , Now for the fir...been able to scientifically prove the pain relievi... as Brazilian mint. , Testing this ancient South ...Graciela Rocha was able to show that when prepared...
(Date:11/24/2009)...new doors to understanding how sounds associated w...e mammal or if they hear it at all. , The same ... NASA uses to detect flaws in the space shuttle,s ...ists to peek inside the giant head of a whale. The...plicas of a whale,s hearing anatomy using a breakt...
(Date:11/24/2009)...and flabby arteries from collapsing have been true...re no longer needed -- once the arteries are stren...ors had no choice but to leave them in place. , ...partment of Biomedical Engineering has developed a...ugs where they,re needed, then dissolves. , "Our...
Breaking Biology News(10 mins):Got a pain? -- Have a cup of Brazilian mint 2Rocket science leads to new whale discovery 2A coating for life 2Rebecca Mader to Illuminate UNICEF Snowflake at Lighting Ceremony in Beverly Hills 61145 1Rebecca Mader to Illuminate UNICEF Snowflake at Lighting Ceremony in Beverly Hills 61145 2Rebecca Mader to Illuminate UNICEF Snowflake at Lighting Ceremony in Beverly Hills 61145 3Conference of International Experts Calls for a Focus on Well Being and The Person in Health 61140 1Conference of International Experts Calls for a Focus on Well Being and The Person in Health 61140 2Conference of International Experts Calls for a Focus on Well Being and The Person in Health 61140 3WellTek MedX Group Completes Major Reorganization 6168 1WellTek MedX Group Completes Major Reorganization 6168 2
...n southern Asia drink groundwater contaminated wit...odia, India, Myanmar and Vietnam die of cancer eac... to the World Health Organization. Some health exp.... , More than 15 years ago, scientists pinpointed...ountains, where sediments containing naturally occ...
...es a new method to track the development of autoim...lated report by Zangani et al, "Tracking early aut...appa;B activation reveals pathology in multiple or...he American Journal of Pathology . , Autoimmune ...toid arthritis and diabetes are caused when the im...
...ake might mean lighting more bush fires, ecologist... of broad-headed snakes are being threatened by en...t, a study by scientists from the University of Sy...Broad-headed snakes are only found living in small...communities are fast becoming extinct or increasin...
Other Biology News:Stanford scientists find new solutions for the arsenic-poisoning crisis in Asia 2Stanford scientists find new solutions for the arsenic-poisoning crisis in Asia 3Stanford scientists find new solutions for the arsenic-poisoning crisis in Asia 4Stanford scientists find new solutions for the arsenic-poisoning crisis in Asia 5Stanford scientists find new solutions for the arsenic-poisoning crisis in Asia 6Stopping autoimmunity before it strikes 2Australia's most endangered snake might need burning 2
Mumps IgG ELISA Kit, Single from Bio-Quant Inc.
Measles IgM ELISA Kit, Single from Bio-Quant Inc.
VZV IgG ELISA Kit, Single from Bio-Quant Inc.
Silencer In Vivo Ready siRNAs from Ambion
Biology Products: